Agency Forms Undergoing Paperwork Reduction Act Review, 40361-40362 [2012-16645]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 131 / Monday, July 9, 2012 / Notices
(0920–0821, expires 9/30/2012), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
CDC is requesting a revision to an
existing data collection of patient-level
clinical, epidemiologic, and
demographic data from ill travelers and
their possible contacts in order to fulfill
its regulatory responsibility to prevent
the importation of communicable
diseases from foreign countries (42 CFR
part 71) and interstate control of
communicable diseases in humans (42
CFR part 70).
Section 361 of the Public Health
Service (PHS) Act (42 U.S.C. 264)
authorizes the Secretary of Health and
Human Services to make and enforce
regulations necessary to prevent the
introduction, transmission or spread of
communicable diseases from foreign
countries into the United States. The
regulations that implement this law, 42
CFR parts 70 and 71, authorize
quarantine officers and other personnel
to inspect and undertake necessary
control measures with respect to
conveyances (e.g., airplanes, cruise
ships, trucks, etc.), persons, and
shipments of animals and etiologic
agents in order to protect the public
health. The regulations also require
conveyances to immediately report an
‘‘ill person’’ or any death on board to
the Quarantine Station prior to arrival in
the United States. An ‘‘ill person’’ is
defined in statute by:
sroberts on DSK5SPTVN1PROD with NOTICES
—Fever (≥100 °F or 38 °C) persisting ≥48
hours.
—Fever (≥100 °F or 38 °C) AND rash,
glandular swelling, or jaundice.
—Diarrhea (≥3 stools in 24 hours or greater
than normal amount).
The 2003 SARS situation and concern
about pandemic influenza and other
communicable diseases have prompted
CDC Quarantine Stations to recommend
that all illnesses be reported prior to
arrival.
CDC Quarantine Stations are currently
located at 20 international U.S. Ports of
Entry. When a suspected illness is
reported to the Quarantine Station,
officers promptly respond to this report
by meeting the incoming conveyance in
person (when possible), collecting
information and evaluating the
patient(s), and determining whether an
ill person can safely be admitted into
the U.S. If Quarantine Station staff are
unable to meet the conveyance, the crew
or medical staff of the conveyance are
trained to complete the required
documentation and forward it (using a
secure system) to the Quarantine Station
for review and follow-up.
VerDate Mar<15>2010
16:20 Jul 06, 2012
Jkt 226001
To perform these tasks in a
streamlined manner and ensure that all
relevant information is collected in the
most efficient and timely manner
possible, Quarantine Stations use a
number of forms—the Air Travel Illness
or Death Investigation Form, Maritime
Conveyance Illness or Death
Investigation Form, and the Land Travel
Illness or Death Investigation Form—to
collect data on passengers with
suspected illness and other travelers/
crew who may have been exposed to an
illness. These forms are also used to
respond to a report of a death aboard a
conveyance.
The purpose of all three forms is the
same: To collect information that helps
quarantine officials detect and respond
to potential public health
communicable disease threats. All three
forms collect the following categories of
information: Demographics and mode of
transportation, clinical and medical
history, and any other relevant facts
(e.g., travel history, traveling
companions, etc.). As part of this
documentation, quarantine public
health officers look for specific signs
and symptoms common to the nine
quarantinable diseases (Pandemic
influenza; SARS; Cholera; Plague;
Diphtheria; Infectious Tuberculosis;
Smallpox; Yellow fever; and Viral
Hemorrhagic Fevers), as well as most
communicable diseases in general.
These signs and symptoms include
fever, difficulty breathing, shortness of
breath, cough, diarrhea, jaundice, or
signs of a neurological infection. The
forms also collect data specific to the
traveler’s conveyance.
These data are used by Quarantine
Stations to make decisions about a
passenger’s suspected illness as well as
its communicability. This in turn
enables Quarantine Station staff to assist
conveyances in the public health
management of passengers and crew.
The estimated total burden on the
public, included in the chart below, can
vary a great deal depending on the
severity of the illness being reported,
the number of contacts, the number of
follow-up inquiries required, and who is
recording the information (e.g.,
Quarantine Station staff versus the
conveyance medical authority). In all
cases, Quarantine Stations have
implemented practices and procedures
that balance the health and safety of the
American public against the public’s
desire for minimal interference with
their travel and trade. Whenever
possible, Quarantine Station staff obtain
information from other documentation
(e.g., manifest order, other airline
documents) to reduce the amount of the
public burden. The total estimated
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
40361
burden requested for this data collection
is 377 hours.
Kimberly S. Lane,
Deputy Director, Office of Science Integrity,
Office of the Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2012–16647 Filed 7–6–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–12–0556]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Assisted Reproductive Technology
(ART) Program Reporting System (0920–
0559, exp. 9/30/2012)—Revision—
National Center for Chronic Disease and
Public Health Promotion (NCDDPHP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The ART program reporting system is
used to comply with Section 2(a) of Pub.
L. 102–493 (known as the Fertility
Clinic Success Rate and Certification
Act of 1992 (FCSRCA)), 42 U.S.C. 263a–
1(a)). FCSRCA requires each ART
program to annually report to the
Secretary through the CDC pregnancy
success rates achieved by each ART
program, the identity of each embryo
laboratory used by such ART program,
and whether the laboratory is certified
or has applied for certification under the
Act. The reporting system allows CDC to
publish an annual success rate report to
Congress as specified by the FCSRCA.
CDC requests OMB approval to
continue information collection for
three years. This Revision request
includes an increase in the total
estimated burden hours due to an
increase in the estimated number of
E:\FR\FM\09JYN1.SGM
09JYN1
40362
Federal Register / Vol. 77, No. 131 / Monday, July 9, 2012 / Notices
responding clinics and an increase in
the estimated number of responses per
respondent. In addition, this Revision
request describes implementation of a
brief, one-time optional feedback survey
at the end of the data submission for
each reporting year. The feedback
survey will elicit information about
ART reporting system usability as well
as respondents’ perspectives on the
usefulness of the information collection.
Information is collected electronically
through the National ART Surveillance
System (NASS), a web-based interface,
or by electronic submission of NASScompatible files. The NASS includes
information about all ART cycles
initiated by any of the ART programs
practicing in the United States and its
territories. The system also collects
information about the pregnancy
outcome of each cycle as well as a
number of data items deemed important
to explain variability in success rates
across ART programs and individuals.
Respondents are the 484 ART
programs in the United States.
Approximately 440 ART programs are
expected to report an average of 339
ART cycles each. The burden estimate
includes the time for collecting,
validating, and reporting the requested
information. Information is collected on
an annual schedule.
There are no costs to the respondents
other than their time. The total
estimated annualized burden hours are
96,960.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Respondents
Form name
ART Programs ................................................
NASS ..............................................................
Feedback Survey ...........................................
Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity,
Office of the Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
the U.S. (OMB No. 0920–0338, exp. 9/
30/2012)—Extension—National Center
for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention
(CDC).
[FR Doc. 2012–16645 Filed 7–6–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day-12–0338]
Agency Forms Undergoing Paperwork
Reduction Act Review
sroberts on DSK5SPTVN1PROD with NOTICES
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Annual Submission of the Ingredients
Added to, and the Quantity of Nicotine
Contained in, Smokeless Tobacco
Manufactured, Imported, or Packaged in
VerDate Mar<15>2010
16:20 Jul 06, 2012
Jkt 226001
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC), Office on Smoking
and Health (OSH) has the primary
responsibility for the Department of
Health and Human Services (HHS)
smoking and health program. HHS’s
overall goal is to reduce death and
disability resulting from the use of
smokeless tobacco products and other
forms of tobacco use through programs
of information, education and research.
Since 1994, as required by the
Comprehensive Smokeless Tobacco
Education Act of 1986 (CSTHEA, 15
U.S.C. 4401 et seq., Pub. L. 99–252),
CDC has collected information about the
ingredients used in smokeless tobacco
products and their nicotine content.
Respondents are commercial smokeless
tobacco product manufacturers,
packagers, or importers (or their
designated representatives), who are
required by the CSTHEA to submit
ingredient reports to HHS on an annual
basis. The legislation also authorizes
HHS to undertake research, and to
report to Congress, as deemed
appropriate, about the health effects of
these ingredients.
Respondents are not required to
submit specific forms; however, they are
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
440
176
Number of
responses per
respondent
339
1
Average
burden per
response
(in hours)
39/60
2/60
required to meet reporting guidelines
and to submit the ingredient report by
chemical name and Chemical Abstract
Service (CAS) Registration Number,
consistent with accepted reporting
practices for other companies currently
required to report ingredients added to
other consumer products. Typically,
respondents submit a summary report to
CDC with the ingredient information for
multiple products, or a statement that
there are no changes to their previously
submitted ingredient report.
Ingredient reports for new products
are due at the time of first importation.
Thereafter, ingredient reports are due
annually on March 31. Information is
submitted to OSH by mailing a written
report on the respondent’s letterhead, by
CD, three-inch floppy disk, or thumb
drive. The information collection is
subject to strict confidentiality
provisions and electronic mail
submissions are not accepted. Upon
receipt and verification of the annual
nicotine and ingredient report, OSH
issues a Certificate of Compliance to the
respondent.
OMB approval is requested for three
years. There are no changes to
information collection procedures or the
estimated burden per response. Due to
an increase in the estimated number of
respondents (from 11 to 13), there is an
increase in the total estimated
annualized burden hours (from 18,843
to 22,269). There are no costs to
respondents other than their time.
E:\FR\FM\09JYN1.SGM
09JYN1
]]>Agencies
[Federal Register Volume 77, Number 131 (Monday, July 9, 2012)]
[Notices]
[Pages 40361-40362]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-16645]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-12-0556]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-7570 or send an email to
omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-5806.
Written comments should be received within 30 days of this notice.
Proposed Project
Assisted Reproductive Technology (ART) Program Reporting System
(0920-0559, exp. 9/30/2012)--Revision--National Center for Chronic
Disease and Public Health Promotion (NCDDPHP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The ART program reporting system is used to comply with Section
2(a) of Pub. L. 102-493 (known as the Fertility Clinic Success Rate and
Certification Act of 1992 (FCSRCA)), 42 U.S.C. 263a-1(a)). FCSRCA
requires each ART program to annually report to the Secretary through
the CDC pregnancy success rates achieved by each ART program, the
identity of each embryo laboratory used by such ART program, and
whether the laboratory is certified or has applied for certification
under the Act. The reporting system allows CDC to publish an annual
success rate report to Congress as specified by the FCSRCA.
CDC requests OMB approval to continue information collection for
three years. This Revision request includes an increase in the total
estimated burden hours due to an increase in the estimated number of
[[Page 40362]]
responding clinics and an increase in the estimated number of responses
per respondent. In addition, this Revision request describes
implementation of a brief, one-time optional feedback survey at the end
of the data submission for each reporting year. The feedback survey
will elicit information about ART reporting system usability as well as
respondents' perspectives on the usefulness of the information
collection.
Information is collected electronically through the National ART
Surveillance System (NASS), a web-based interface, or by electronic
submission of NASS-compatible files. The NASS includes information
about all ART cycles initiated by any of the ART programs practicing in
the United States and its territories. The system also collects
information about the pregnancy outcome of each cycle as well as a
number of data items deemed important to explain variability in success
rates across ART programs and individuals.
Respondents are the 484 ART programs in the United States.
Approximately 440 ART programs are expected to report an average of 339
ART cycles each. The burden estimate includes the time for collecting,
validating, and reporting the requested information. Information is
collected on an annual schedule.
There are no costs to the respondents other than their time. The
total estimated annualized burden hours are 96,960.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
ART Programs.......................... NASS.................... 440 339 39/60
Feedback Survey......... 176 1 2/60
----------------------------------------------------------------------------------------------------------------
Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2012-16645 Filed 7-6-12; 8:45 am]
BILLING CODE 4163-18-P
